{"value":{"id":1935596,"askingMemberId":5327,"askingMember":null,"house":"Commons","memberHasInterest":false,"dateTabled":"2026-08-28T00:00:00","dateForAnswer":"2026-09-03T00:00:00","uin":"25137","questionText":"To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of the MHRA-NICE aligned pathway that came into force on 1 April 2026 on the pricing of self-funded treatment and medications.","answeringBodyId":17,"answeringBodyName":"Department of Health and Social Care","isWithdrawn":false,"isNamedDay":true,"groupedQuestions":[],"answerIsHolding":false,"answerIsCorrection":false,"answeringMemberId":4637,"answeringMember":null,"correctingMemberId":null,"correctingMember":null,"dateAnswered":"2026-09-07T00:00:00","answerText":"<p>The Government has not made any assessment of the impact of the aligned pathway on the pricing of self-funded treatments and medicines. The pathway aims to speed up access for National Health Service patients to clinically and cost-effective medicines by three to six months by streamlining regulatory and appraisal processes.</p>","originalAnswerText":"","comparableAnswerText":"","dateAnswerCorrected":null,"dateHoldingAnswer":"2026-09-04T00:00:00","attachmentCount":0,"heading":"Drugs and Medical Treatments: Fees and Charges","attachments":[],"groupedQuestionsDates":[]},"links":[{"rel":"self","href":"/Questions/1935596","method":"GET"}]}